Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) EBIT Margin (2016 - 2026)

Healthequity has reported EBIT Margin over the past 14 years, most recently at 21.24% for Q1 2026.

  • For Q1 2026, EBIT Margin rose 772.0% year-over-year to 21.24%; the TTM value through Jan 2026 reached 24.55%, up 1102.0%, while the annual FY2026 figure was 24.55%, 1102.0% up from the prior year.
  • EBIT Margin for Q1 2026 was 21.24% at Healthequity, down from 24.43% in the prior quarter.
  • Over five years, EBIT Margin peaked at 27.5% in Q3 2025 and troughed at 13.4% in Q1 2022.
  • A 5-year average of 11.14% and a median of 12.4% in 2023 define the central range for EBIT Margin.
  • Biggest five-year swings in EBIT Margin: crashed -1256bps in 2022 and later soared 1906bps in 2023.
  • Year by year, EBIT Margin stood at 2.56% in 2022, then skyrocketed by 383bps to 12.4% in 2023, then tumbled by -47bps to 6.53% in 2024, then surged by 274bps to 24.43% in 2025, then fell by -13bps to 21.24% in 2026.
  • Business Quant data shows EBIT Margin for HQY at 21.24% in Q1 2026, 24.43% in Q4 2025, and 27.5% in Q3 2025.